P E Tagne Kamdem

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
INTRODUCTION The aim of this study was to evaluate the incidence and risk factors of residual pleural opacity (RPO) at the end and after 6 months (M12) of antituberculosis treatment (ATT) in adults with pleural tuberculosis. METHODS In this prospective cohort study, all patients admitted for pleural tuberculosis between September 2010 and August 2012 in(More)
  • 1